Champions Oncology nets $14 mln

Hackensack, New Jersey-based Champions Oncology Inc, a developer of advanced tech solutions to personalize the use of oncology drugs, has closed $14 million in funding. New Enterprise Associates led the round with participation from other investors that included Battery Ventures, Perceptive Advisors and Sabby Capital. MTS Securities, LLC, an affiliate of MTS Health Partners LP, served as the placement agent.

PhaseBio Pharmaceuticals picks up $40 mln Series C

Malvern, Pennsylvania-based PhaseBio Pharmaceuticals Inc, which is focused on developing treatments for metabolic and specialty cardiopulmonary disorders, has secured $40 million in Series C funding. AstraZeneca led the round with participation from New Enterprise Associates, Hatteras Venture Partners, Johnson & Johnson Innovation – JJDC and Fletcher Spaght Ventures. In addition to the funding, Dr. Michael Gutch of AstraZeneca has been added to PhaseBio’s board of directors while Donald Dwyer, also of AstraZeneca, has become a board observer.


NEA, others seed enterprise productivity platform Do

Do, which provides a productivity platform for the enterprise, has raised $2 million in seed funding from New Enterprise Associates, Slow Ventures (Dave Morin and Kevin Colleran), Nas of Queensbridge Venture Partners, Zynga founder Mark Pincus, Chegg co-founder Aayush Phumbhra, Cotap CEO and former Yammer Chief Product Officer Jim Patterson, and other investors. The San Francisco-based company, which allows users to take notes, share files, assign tasks, and do related meeting tasks, launched in July 2014 with an undisclosed amount of initial backing, including from SherpaVentures and Salesforce.


VC-backed SugarCRM buys Stitch

SugarCRM Inc has acquired San Francisco-based Stitch, a provider of personal assistant technologies that enhance productivity for mobile users. No financial terms were disclosed. SugarCRM is backed by Goldman Sachs, Draper Fisher Jurvetson, New Enterprise Associates and Walden International.


NEA leads $13 mln Series B funding in Swiftype

New Enterprise Associates has led a $13 million Series B funding round in Swiftype, a software-as-a-service startup for web and mobile app searching. As part of the funding, NEA Partner Chetan Puttagunta will join Swiftype’s board of directors. Swiftype previously raised $7.5 million in a Series A funding in late 2013.


NEA leads $35 mln round for Mersana

Cambridge, Massachusetts-based Mersana Therapeutics Inc, a provider of Fleximer antibody-drug conjugate technology, has secured $35 million in Series B-1 financing. New Enterprise Associates led the round with participation from Rock Springs Capital Management, Elliott Sigal, former head of R&D at Bristol-Myers Squibb, Pfizer Venture Investments and Fidelity Biosciences. Also, Mersana has appointed Anna Protopapas as president and CEO. And, Protopapas and Dr. Elaine V. Jones, executive director of Pfizer Venture Investments, have been added to Mersana’s board of directors.

Branch Metrics pulls in $15 mln Series A

Palo Alto, California-based mobile linking platform Branch Metrics has raised $15 million in Series A funding. New Enterprise Associates and Ben Narasin led the round with participation from Pejman Mar Ventures, Zach Coelius, Cowboy Ventures and TriplePoint Capital.


GuideSpark raises $22.2 mln

GuideSpark has closed a Series C funding round $22.2 million led by Meritech Capital Partners with participation from existing investors New Enterprise Associates (NEA), Storm Ventures and IDG Ventures. Menlo Park, Calif.-based GuideSpark provides videos that aide in employee communications and engagement.


ScienceLogic picks up $43 mln in Goldman Sachs-led round

Goldman Sachs has led a $43 million Series D funding round for ScienceLogic. The company’s previous backers New Enterprise Associates and Intel Capital also participated in the round. Headquartered in Reston, Virginia, ScienceLogic is a provider of IT monitoring software.


Springpath seals $34 mln

Sunnyvale, California-based Springpath, a provider of enterprise-grade storage and data management software, has raised $34 million from Sequoia Capital, New Enterprise Associates and Redpoint Ventures. Springpath has been in stealth mode since May 2012.


Moda Operandi attracts $60 mln Series E

Online luxury retailer Moda Operandi has secured $60 million in Series E funding. Fidelity Investments led the round with participation from investors that included New Enterprise Associates, Advanced Publications Inc, the parent company of Conde Nast, New Atlantic Ventures, LVMH and RRE Ventures.

Cortendo closes about $26.4 mln in a private placement

Cortendo AB has raised about $26.4 million in a private placement. The investors were RA Capital Management, New Enterprise Associates, Broadfin Capital and HealthCap. Headquartered in Göteborg, Sweden and with offices in Radnor, Pennsylvania, Cortendo is a biopharmaceutical firm focused on orphan endocrine disorders.


E-commerce site Jet raises $140 mln

Stealth e-commerce startup Jet announced it has raise $140 million in new funding led by Bain Capital Ventures. Also participating in the round are Accel Partners, Coatue Management, General Catalyst Partners, Goldman Sachs, Google Ventures, MentorTech Ventures, New Enterprise Associates, Norwest Venture Partners, Silicon Valley Bank, Temasek, Thrive Capital and others.


FiscalNote attracts $10 mln Series B

Washington, DC-based legislative and regulatory analytics firm FiscalNote has secured $10 million in Series B funding. Renren led the round with participation from previous backers that included Visionnaire Ventures, New Enterprise Associates, Jerry Yang/AME Cloud Ventures, Steve Case and Mark Cuban.


VC-backed Zosano Pharma rolls out IPO

Zosano Pharma Corp has launched its IPO after pricing its 4.5 million shares at $11 per share. The stock began trading Tuesday on the NASDAQ under the ticker symbol “ZSAN.” Ladenburg Thalmann and Roth Capital Partners are serving as lead underwriters. Based in Fremont, California, Zosano is a biopharmaceutical company focused on transdermal drug delivery. Its backers include Nomura International, BioMed Ventures, HBM BioVentures, New Enterprise Associates and ProQuest Investments.


Scout raises $2.75 mln from NEA, Google Ventures

Scout, which offers a cloud-based solution for filling out requests for proposals, has raised $2.75 million in seed funding. New Enterprise Associates led the funding, with participation from Google Ventures, Zapis Capital and angel investors, including Techammer and Tim O’Shaughnessy. As part of the seed funding, Chetan Puttagunta, a partner at NEA, has joined the board of the Cleveland,Ohio-based company.


NEA leads $56 mln Series B funding in Raise

New Enterprise Associates has led a $56 million Series B funding round in Raise, an online marketplace for gift cards. Other participants in the funding round include Bessemer Venture Partners, the Pritzker Organization, Listen Ventures and existing angel investors. The funding brings Raise’s total capital raised to $81 million. Tony Florence, general partner at NEA, will join Raise’s board of directors.


Pluribus Networks pulls in $50 mln Series D

Pluribus Networks, an SDN platform provider, has raised $50 million in Series D funding. Temasek Holdings led the round with participation from previous backers that included New Enterprise Associates, Menlo Ventures, Mohr Davidow and AME Cloud Ventures.

PE HUB Community

Join the 12515 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget